National Advisory Council Agenda

137th Meeting of the National Advisory Council on Drug Abuse

Virtual Meeting – February 9, 2021

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

10:45 a.m. – 12:30 p.m.

10:45 a.m. Call to Order
Nora Volkow, M.D.
Director, NIDA


Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
11:00 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Kurt Rasmussen, Ph.D., Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Research Training, Diversity, and Disparities (ORTDD)
Albert Avilla, Ph.D., Deputy Director

  Brief Break
12:00 p.m. Report to Council from the BSC
Amy Newman, Ph.D., Director, NIDA IRP
Regina Carelli, Ph.D., BSC Chair
12:30 p.m. Break

Videocast:

Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Dr. Gillian Acca, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.

https://videocast.nih.gov/watch=41305

Open Session

1:15 - 4:30 p.m.

1:15 p.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
1:30 p.m. Director's Report
Nora Volkow, M.D. Director, NIDA
2:20 p.m. Discussion
Council Members
2:40 p.m. Standardized Unit of Measure for Cannabis Research
Susan Weiss, Ph.D.
Director, Division of Extramural Research
Emily Einstein, Ph.D.
Chief, Science Policy Branch, OSPC
3:10 p.m. NIDA Meetings Report
  • Social Determinants of Opioid Use: Establishing a Research Agenda to Inform Community and System Level Interventions
    Aria Crump, Sc.D.
    Deputy Chief, Prevention Research Branch, DESPR
  • Adolescent Brain Cognitive Development Study Principle Investigators Meeting
    Gaya Dowling, Ph.D.
    Director, ABCD Study

    Steve Grant, Ph.D.
    Health Scientist Administrator, DNB
4:10 p.m. Concept Clearances​
  • Division of Therapeutics and Medical Consequences (DTMC)
    • Medications Development Initiative – David McCann, Ph.D., Associate Director
    • Abuse Liability Testing Initiative – David McCann, Ph.D., Associate Director
    • Drug Supply Program – Rik Kline, Ph.D., Chief, Chemistry and Pharmaceutics Branch
    • Developing Digital Therapeutics for Substance Use Disorders – Will Aklin, Ph.D. Health Scientist Administrator
  • Division of Epidemiology, Services, and Prevention Research (DESPR)
    • Population Assessment of Tobacco and Health (PATH) Study – Heather Kimmel, Ph.D., Health Scientist Administrator
  • Division of Extramural Research (DER)
    • Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study – Elizabeth Hoffman, Ph.D., Scientific Program Manager, ABCD Study
  • Office of Translational Initiatives and Program Innovations (OTIPI)
    • Mobile Health Solutions to Rectify Digital Inequality in Communities Affected By Drug Addiction – Leonardo Angelone, Ph.D., Deputy Director
    • Advancing Pharmacotherapeutics for Substance Use Disorders (SUD): Focus on Pre-Clinical Development  – Ram Arudchandran, Ph.D., Health Scientist Administrator
    • Leveraging Artificial Intelligence (AI) Tools for Substance Use Disorders (SUD) Drug Discovery and Development – Ram Arudchandran, Ph.D., Health Scientist Administrator
  • Division of Neuroscience and Behavior (DNB)
    • Genetic Analysis of Non-Human Animal Models to Understand the Genomic Architecture of Substance Use Disorders and Addictive Behaviors – Amy Lossie, Ph.D., Health Scientist Administrator
    • Imaging-Science Track Award for Research Transition – John Fedota, Ph.D., Health Scientist Administrator
4:20 p.m. Public Comments
4:30 p.m. Adjourn